经济分析、资本诉求与国家药物政策研究:一个理论框架

Economic Analysis,Capital's Appeal for Value and the National Drug Policy:Based on Theory Structure

市场价值不同于道德或者伦理价值,当我们致力于研究国家药物政策时,应当清醒地意识到,尽管从总体目标来看国家药物政策本身体现了社会认可的公平性以及社会伦理的基本观念,但是,其实际的制订与实施很可能是一次又一次的利益博弈,不同的利益群体所认可的价值存在着根本性的差异。作为一种制度安排,国家药物政策的制订及其实施必定涉及到经济利益。制药企业是经济利益最主要的关联方,对于制药企业而言,国家药物政策中的经济目标和可能引致的经济后果是其所唯一关注的,并在国家药物政策从制订到实施的不同层级中寻求最大化其经济利益的可能。

Market value is different from moral or ethical value.It should be considered that when national drug policy is researched,that the development and implementation of NDP is probably a repeated game of interests,although the national drug policy itself is full of social recognized fairness and the basic concepts of ethics.Different interest groups are different in views of value and this needs to be considered.As an institution arrangement,the development and implementation of NDP must be related to economic interests and can not bypass the distribution and redistribution of economic interests.Pharmaceutical companies are the main affiliated parties of economic interests whose only concern is the economic consequences maybe caused by the NDP and its economic goals and who will seek possibilities can maximize their economic interests at different levels of the development and implementation of NDP.